Español
Español English Português 日本

Articles

Article

Diabetic Re-Entry Retinopathy

Eyes on Eyecare
abril 2025
In this episode of Ready, Set, Retina, Dr. Paul Chous shares how a patient’s vision worsened after a rapid drop in blood sugar. He highlights the need for careful monitoring when making big changes to diabetes treatment.
LEE AHORA
Article

3 Optometry Practice Investments = $552K Annually

Review of Optometric Business
octubre 2024
Investing in technology can significantly enhance patient care while boosting profitability for optometry practices. This article highlights three key technological additions that were made to achieve these outcomes.
LEE AHORA
Article

VEP to the Rescue

Review of Optometry
octubre 2024
This article discusses where to turn when you are providing treatment in the form of lenses and vision therapy and are not seeing the improvement that you expect.
LEE AHORA
Article

Devices You Might Not Have: Are They a Good Fit?

Review of Optometry
septiembre 2024
This article explores a diverse selection of newer optometric devices, as well as those used in specialized areas of care, designed to help you enhance your skills and advance in specific fields of optometry.
LEE AHORA
Article

3 ROI Winners that Generated $200,000+ Last Year

Review of Optometric Business
junio 2024
Dr. Melissa Richard writes about 3 clear winners in her quest to enhance care and spur financial growth, one of them being the RETeval handheld ERG, which she uses to manage her diabetic and low vision patients.
LEE AHORA
Article

8 Reasons to Focus on Diabetes in Your Practice

Review of Optometric Business
mayo 2024
Dr. Dorothy Hitchmoth explains how the positive impact on public health and the financial rewards make diabetes care a cornerstone for the success and sustainability of optometrists who are willing to embrace this transformative approach.
LEE AHORA
LKC_AMETEK_website_logo_RGB_color
© 2026 LKC Technologies, Inc.

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity